Cottrell Graeme S, Padilla Benjamin, Pikios Stella, Roosterman Dirk, Steinhoff Martin, Grady Eileen F, Bunnett Nigel W
Department of Surgery, University of California, San Francisco, California 94143-0660, USA.
J Biol Chem. 2007 Apr 20;282(16):12260-71. doi: 10.1074/jbc.M606338200. Epub 2007 Feb 19.
Calcitonin receptor-like receptor (CLR) and the receptor activity-modifying protein 1 (RAMP1) comprise a receptor for calcitonin gene-related peptide (CGRP). Although CGRP induces endocytosis of CLR/RAMP1, little is known about post-endocytic sorting of these proteins. We observed that the duration of stimulation with CGRP markedly affected post-endocytic sorting of CLR/RAMP1. In HEK and SK-N-MC cells, transient stimulation (10(-7) M CGRP, 1 h), induced CLR/RAMP1 recycling with similar kinetics (2-6 h), demonstrated by labeling receptors in living cells with antibodies to extracellular epitopes. Recycling of CLR/RAMP1 correlated with resensitization of CGRP-induced increases in Ca(2+). Cycloheximide did not affect resensitization, but bafilomycin A(1), an inhibitor of vacuolar H(+)-ATPases, abolished resensitization. Recycling CLR and RAMP1 were detected in endosomes containing Rab4a and Rab11a, and expression of GTPase-defective Rab4aS22N and Rab11aS25N inhibited resensitization. After sustained stimulation (10(-7) M CGRP, >2 h), CLR/RAMP1 trafficked to lysosomes. RAMP1 was degraded approximately 4-fold more rapidly than CLR (RAMP1, 45% degradation, 5 h; CLR, 54% degradation, 16 h), determined by Western blotting. Inhibitors of lysosomal, but not proteasomal, proteases prevented degradation. Sustained stimulation did not induce detectable mono- or polyubiquitination of CLR or RAMP1, determined by immunoprecipitation and Western blotting. Moreover, a RAMP1 mutant lacking the only intracellular lysine (RAMP1K142R) internalized and was degraded normally. Thus, after transient stimulation with CGRP, CLR and RAMP1 traffic from endosomes to the plasma membrane, which mediates resensitization. After sustained stimulation, CLR and RAMP1 traffic from endosomes to lysosomes by ubiquitin-independent mechanisms, where they are degraded at different rates.
降钙素受体样受体(CLR)和受体活性修饰蛋白1(RAMP1)构成降钙素基因相关肽(CGRP)的一种受体。尽管CGRP可诱导CLR/RAMP1的内吞作用,但对于这些蛋白的内吞后分选情况却知之甚少。我们观察到,CGRP刺激的持续时间显著影响CLR/RAMP1的内吞后分选。在人胚肾(HEK)细胞和SK-N-MC细胞中,短暂刺激(10⁻⁷ M CGRP,1小时)可诱导CLR/RAMP1以相似的动力学进行循环(2 - 6小时),这通过用针对细胞外表位的抗体标记活细胞中的受体得以证实。CLR/RAMP1的循环与CGRP诱导的细胞内钙离子浓度([Ca²⁺]i)升高的再敏化相关。放线菌酮不影响再敏化,但液泡H⁺ - ATP酶抑制剂巴弗洛霉素A₁可消除再敏化。在含有Rab4a和Rab11a的内体中检测到循环的CLR和RAMP1,并且GTP酶缺陷型Rab4aS22N和Rab11aS25N的表达抑制了再敏化。在持续刺激(10⁻⁷ M CGRP,>2小时)后,CLR/RAMP1转运至溶酶体。通过蛋白质印迹法测定,RAMP1的降解速度比CLR快约4倍(RAMP1,45%降解,5小时;CLR,54%降解,16小时)。溶酶体蛋白酶抑制剂而非蛋白酶体蛋白酶抑制剂可阻止降解。通过免疫沉淀和蛋白质印迹法测定,持续刺激未诱导CLR或RAMP1出现可检测到的单泛素化或多泛素化。此外,缺乏唯一细胞内赖氨酸的RAMP1突变体(RAMP1K142R)可正常内化并降解。因此,在用CGRP短暂刺激后,CLR和RAMP1从内体转运至质膜,这介导了再敏化。在持续刺激后,CLR和RAMP1通过不依赖泛素的机制从内体转运至溶酶体,并在溶酶体中以不同速率降解。